Brainstorm Cell Therapeutics Inc. | Key People and Executives
Uri Yablonka
Director, Chief Business Officer & Executive VP
Arturo O. Araya
Independent Director & Chief Commercial Officer
Anthony J. Polverino
Independent Director
June Sherie Almenoff
Independent Director
Malcolm S. Taub
Independent Director
Chaim Lebovits
President & Chief Executive Officer
Ralph Z. Kern
Chief Operating & Medical Officer
Eyal Rubin
Chief Financial Officer, Treasurer & Executive VP
Revital Geffen-Aricha
Vice President-Research & Development
Yael Gothelf
Vice President-Scientific & Regulatory Affairs
Susan E. Ward
Head-Clinical Operations
Uri Yablonka
Director, Chief Business Officer & Executive VP
Yossef Levy
Vice President-Cell Production
Joseph Petroziello
VP-Scientific & Corporate Communications
Mary Kay Turner
VP-Patient Advocacy & Government Affairs
Arturo O. Araya
Independent Director & Chief Commercial Officer
Anthony J. Polverino
Independent Director
June Sherie Almenoff
Independent Director
Malcolm S. Taub
Independent Director
| Address |
1325 Avenue of Americas
New York New Jersey 10019
United States
|
|
Employees
|
- |
| Website |
http://www.brainstorm-cell.com |
| Updated |
07/08/2019 |
| Brainstorm Cell Therapeutics, Inc. operates as a biotechnology company, which develops and commercializes adult stem cell therapeutic products. It focuses on utilizing the patients own bone marrow stem cells to generate neuron-like cells that may provide an effective treatment initially for amyotrophic lateral sclerosis, Parkinson's disease, multiple sclerosis and spinal cord injury. The company was founded on September 22, 2000 and is headquartered in New York, NJ. |
